Femannose D-Mannose

Femannose N, containing the natural ingredient D-Mannose, is suitable for the acute treatment and low-dose prevention of bladder infections, without causing resistance in E. coli bacteria. Bladder infection? It doesn’t always have to be an antibiotic! Today, more than 50% of women who visit a doctor for a urinary tract infection receive antibiotics for the treatment of bladder infections. However, the development of resistance, especially in E. coli bacteria—which are responsible for about 80-90% of urinary tract infections—has significantly increased in recent years. On a health policy level, strategies have already been initiated to reduce the excessive use of antibiotics. For uncomplicated, acute cystitis caused by E. coli bacteria, Femannose can make a valuable contribution to avoiding unnecessary antibiotic use.

Femannose N tackles the root cause with the ingredient D-Mannose. D-Mannose reaches the bladder unchanged within an hour of ingestion. The binding sites on the fimbriae of E. coli bacteria are occupied by the supplied D-Mannose. This way, the E. coli bacteria remain in the urine and are flushed out of the body during urination. Due to its rapid onset of action and the absence of resistance development in E. coli bacteria, Femannose N is very well suited for the treatment of acute, uncomplicated bladder infections. When taken in low doses, it can also be used for prevention. Femannose N is suitable for diabetics, vegan, free from gluten, lactose, and preservatives. The fruity taste is pleasant and contributes to high patient compliance.